
Mal-ID uses AI to enable early cancer screening, starting with oral cancer. It analyzes medical images to identify visual signs of cancer before symptoms appear. The core technology is AI-powered image analysis for visual screening, targeting healthcare providers and clinics. The product category is B2B AI medical imaging software with potential data ecosystem for AI modeling. The market is large and growing as early detection improves outcomes, with scalable deployment across health systems.

Mal-ID uses AI to enable early cancer screening, starting with oral cancer. It analyzes medical images to identify visual signs of cancer before symptoms appear. The core technology is AI-powered image analysis for visual screening, targeting healthcare providers and clinics. The product category is B2B AI medical imaging software with potential data ecosystem for AI modeling. The market is large and growing as early detection improves outcomes, with scalable deployment across health systems.